Skip to main content

Advertisement

Table 3 Animal information and SD 60 treatment dosages (Groups 1–5)

From: Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis

Treatment group Animal identification Sex Body weight (lb)     
Ivermectin/Pyrantel     Tablet administered Dose
(Group 1)     Ivermectin (μg) Pyrantel (mg) Ivermectin (μg/kg) Pyrantel (mg/kg)
  IDF-2 M 29.6 136 114 10.1 8.5
  UHH-2 M 25.7 136 114 11.6 9.8
  VTH-2 M 24.1 68 57 6.2 5.2
  IOF-2 M 23.7 68 57 6.3 5.3
  BFG-2 F 24.2 68 57 6.2 5.2
  PXC-2 F 21.6 68 57 6.9 5.8
  VVH-2 M 22.8 68 57 6.6 5.5
  GSC-2 F 20.2 68 57 7.4 6.2
Milbemycin/Spinosad     Tablet administered Dose
(Group 2)     Milbemycin (mg) Spinosad (mg) Milbemycin (mg/kg) Spinosad (mg/kg)
  FCG-2 F 24.7 9.3 560 0.8 49.9
  IUE-2 F 26.4 9.3 560 0.8 46.7
  UDH-2 M 23.8 9.3 560 0.9 51.8
  VCG-2 F 22.5 9.3 560 0.9 54.8
  TPH-2 M 28.3 9.3 560 0.7 43.5
  XBH-2 M 21.8 9.3 560 0.9 56.5
  EZG-2 F 22.6 9.3 560 0.9 54.5
  KUH-2 M 19.1 4.5 270 0.5 31.1
Selamectin     Applicator tube Dose
(Group 3)     Selamectin (mg) Selamectin (mg/kg)
  OFF-2 M 27.1 120 9.8
  VUH-2 M 26.3 120 10.0
  EYE-2 F 24.6 120 10.7
  UKG-2 F 20.7 120 12.8
  AVG-2 F 22.6 120 11.7
  GPG-2 F 21.8 120 12.1
  GDE-2 F 21.8 120 12.1
  ZXG-2 F 20.2 120 13.1
Moxidectin/Imidacloprid     Applicator tube Dose
(Group 4)     Moxidectin (mg) Imidacloprid (mg) Moxidectin (mg/kg) Imidaclopridd (mg/kg)
  DIH-2 M 26.1 NA NA NA NA
  UYH-2 M 27.1 NA NA NA NA
  CGH-2 M 24.8 NA NA NA NA
  FKC-2 F 21.6 NA NA NA NA
  FJC-2 F 22.2 NA NA NA NA
  VZG-2 F 20.6 NA NA NA NA
  LAG-2 F 20.1 NA NA NA NA
  THH-2 M 20.3 NA NA NA NA
Non-treated control      
(Group 5) UTH-2 M 27.6 NA NA NA NA
  GKC-2 F 25.7 NA NA NA NA
  TWH-2 M 23.9 NA NA NA NA
  EDG-2 F 23.2 NA NA NA NA
  RAF-2 M 24.4 NA NA NA NA
  CRC-2 F 21.4 NA NA NA NA
  TJH-2 M 24.2 NA NA NA NA
  IXG-2 F 20.7 NA NA NA NA